Trials / Withdrawn
WithdrawnNCT02673866
Study to Evaluate the Efficacy and Safety of DS-1971a for the Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)
A Randomized Double-Blind Placebo and Active Controlled Parallel Group Study to Evaluate the Efficacy and Safety of DS-1971a for the Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Daiichi Sankyo · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The hypothesis of this Phase 2 study is that at least 1 dose regimen of DS-1971a will demonstrate clinical superiority to placebo in managing pain associated with DPNP, and will be generally well tolerated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DS-1971a | |
| DRUG | placebo | |
| DRUG | pregabalin | pregabalin |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2017-01-01
- Completion
- 2017-02-01
- First posted
- 2016-02-04
- Last updated
- 2016-07-27
Source: ClinicalTrials.gov record NCT02673866. Inclusion in this directory is not an endorsement.